Literature DB >> 13129644

Uncovering genomic differences in human pathogenic Yersinia enterocolitica.

Andrey Golubov1, Jürgen Heesemann, Alexander Rakin.   

Abstract

To map out genomic differences between highly pathogenic Yersinia enterocolitica WA-314C biogroup 1B, serotype O:8 strain and low-pathogenic Y. enterocolitica Y-108C biogroup 4, serotype O:3 strain we have applied a method of suppression subtractive hybridization (SSH). In total, 428 WA-314-specific and 83 Y-108-specific sequences were uncovered by SSH. Among them were DNA fragments with similarity to known genes from several groups: (1) genes involved in O-antigen biosynthesis, (2) host-specific restriction-modification systems, (3) systems of iron and heme acquisition and storage, (4) flagellar biogenesis genes, (5) putative virulence factors, (6) drug resistance genes, and (7) mobile elements. Mapped out genomic differences may be applied in identification and development of novel therapeutic strategies for the treatment of enteropathogenic Yersinia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13129644     DOI: 10.1016/S0928-8244(03)00182-2

Source DB:  PubMed          Journal:  FEMS Immunol Med Microbiol        ISSN: 0928-8244


  4 in total

Review 1.  Ca2+-binding motif of βγ-crystallins.

Authors:  Shanti Swaroop Srivastava; Amita Mishra; Bal Krishnan; Yogendra Sharma
Journal:  J Biol Chem       Date:  2014-02-24       Impact factor: 5.157

Review 2.  Detection of Yersinia enterocolitica in food: an overview.

Authors:  V Gupta; P Gulati; N Bhagat; M S Dhar; J S Virdi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-20       Impact factor: 3.267

Review 3.  Translocated effectors of Yersinia.

Authors:  Hiroyuki Matsumoto; Glenn M Young
Journal:  Curr Opin Microbiol       Date:  2009-02       Impact factor: 7.934

Review 4.  A comprehensive review on the prevalence, pathogenesis and detection of Yersinia enterocolitica.

Authors:  Muhammad Shoaib; Aamir Shehzad; Husnain Raza; Sobia Niazi; Imran Mahmood Khan; Wasim Akhtar; Waseem Safdar; Zhouping Wang
Journal:  RSC Adv       Date:  2019-12-11       Impact factor: 4.036

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.